Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04328467 · ClinicalTrials.gov registry record · Phase 3
Pre-exposure Prophylaxis for SARS-Coronavirus-2
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,483
- Enrollment target
NCT04328467 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 1,483 participants.
The verdict
NCT04328467, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,483 participants
- Enrollment target
Study Summary
Objective: To determine if pre-exposure prophylaxis with hydroxychloroquine is effective for the prevention of COVID-19 disease.
Interventions
- OTHER Placebo
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,483 participants |
| Start Date | 2020-04-06 |
| Est. Completion | 2020-07-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04328467
The ClinicalTrials.gov registry entry for NCT04328467 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04328467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04328467 about?
NCT04328467 is a clinical study titled "Pre-exposure Prophylaxis for SARS-Coronavirus-2". Objective: To determine if pre-exposure prophylaxis with hydroxychloroquine is effective for the prevention of COVID-19 disease.
What is the current status of trial NCT04328467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,483 participants. The study started on 2020-04-06. Estimated completion is 2020-07-13.
What interventions are being tested in trial NCT04328467?
The interventions under investigation include: Placebo (OTHER), Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04328467?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.